Alprazolam updated on 02-10-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.50 [0.96, 2.35]85%3 studies206,5511,999not evaluable ROB-
Congenital heart defects1.31 [0.74, 2.32]82%3 studies95,8471,987not evaluable ROB-
Major congenital malformations1.53 [0.93, 2.51]92%2 studies206,5311,917not evaluable ROB-
Hypospadias0.30 [0.10, 0.90]-1 study2,540not evaluable ROB6.12 [.; 1.46]
Oesophageal atresia with or without tracheo-oesophageal fistula2.70 [1.22, 5.99]-1 study75346not evaluable ROB4.84 [1.73; .]
Anophthalmos/micropthalmos4.00 [1.21, 13.22]-1 study23041not evaluable ROB7.46 [1.72; .]
Atresia or stenosis of other parts of small intestine--0 study-
Bilateral renal agenesis including Potter syndrome--0 study-
Club foot / Talipes equinovarus--0 study-
Ear malformations--0 study-
Genital anomalies--0 study-
Limb reduction defects (LRD)--0 study-
Microcephaly / Small head circumference for gestational age--0 study-
Oro-facial clefts--0 study-
Polydactyly--0 study-
23 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Small for gestational age (weight)2.05 [0.57, 7.42]83%2 studies277,48314,187not evaluable ROB-
Low birth weight (< 2500g)2.11 [0.72, 6.12]48%2 studies32128not evaluable ROB-
Preterm (< 37 weeks)1.40 [0.81, 2.41]49%2 studies276,19914,220not evaluable ROB-

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
1 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Low Apgar score (< 7) (at 1 min)--0 study-
Low Apgar score (< 7) (at 5 min)--0 study-
1 non statistically significant endpoints reported in only one study

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions1.70 [1.22, 2.38]53%3 studies27,201196not evaluable ROB2.80 [1.74; .]
Late intrauterine deaths (> 22 weeks) / Stillbirths0.99 [0.84, 1.16]0%2 studies32,53414,395not evaluable ROB-
1 non statistically significant endpoints reported in only one study